Companies in the Services sector have received a lot of coverage today as analysts weigh in on Celularity (CELU – Research Report) and Madison Square Garden Entertainment (MSGE – Research Report).
Celularity (CELU)
Morgan Stanley analyst Jeffrey Hung maintained a Sell rating on Celularity yesterday and set a price target of $1.00. The company’s shares closed last Monday at $0.74, close to its 52-week low of $0.55.
According to TipRanks.com, Hung is a 5-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Celularity with a $1.75 average price target.
See today’s best-performing stocks on TipRanks >>
Madison Square Garden Entertainment (MSGE)
Morgan Stanley analyst Benjamin Swinburne maintained a Hold rating on Madison Square Garden Entertainment today and set a price target of $70.00. The company’s shares closed last Monday at $57.65.
According to TipRanks.com, Swinburne is a 5-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Madison Square Garden Entertainment with a $70.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CELU:
- Celularity Receives U.S. Food And Drug Administration (FDA) Preliminary Assessment For Celularity’s Investigational Fuse Bone Void Filler To Be Regulated As A Device By FDA’s Center For Devices And Radiological Health
- Celularity in product distribution pact with ADPORTS across Middle East
- Celularity Announces Agreement with AD Ports Group for Exclusive Product Distribution in Various Territories in the Gulf Cooperation Council Regions and Egypt
- Celularity Inc. (CELU) Q4 Earnings Cheat Sheet
